Inhibition of alpha(5)beta(1)integrin with the clinically validated small peptide, ATN-161 stabilizes cerebral vasculature, reduces inflammation, and decreases blood-brain barrier permeability after experimental ischemic stroke

FASEB JOURNAL(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要